Glutathione supplements protect preterm rabbits from oxidative lung injury

Area of Science:

• Biomedical Science
• Neonatology
• Pulmonology

Background:

• Hyperoxic lung injury is a significant concern in preterm infants.
• Oxidative stress plays a key role in the pathogenesis of lung damage.
• Glutathione (GSH) is a critical endogenous antioxidant.

Purpose of the Study:

• To investigate the protective effects of glutathione (GSH) supplementation against hyperoxic lung injury in a preterm rabbit model.
• To determine if GSH administration can attenuate lung dysfunction and damage induced by hyperoxia.

Main Methods:

• Preterm rabbits (29 days gestation) were exposed to room air or 95% oxygen for 24 hours.
• Glutathione (GSH) was administered via nutritional support (10% dextrose and saline) through a peritoneal catheter.
• Lung mechanics, edema, cell viability, and GSH levels (tissue and lavage) were assessed.

Main Results:

• Hyperoxia exposure led to decreased lung volumes, reduced compliance, increased edema, and lower cell viability compared to controls.
• Animals exposed to oxygen and supplemented with GSH showed no significant differences from room air controls in lung mechanics, edema, or cell viability.
• GSH supplementation maintained normal lung tissue and lavage GSH levels in animals exposed to hyperoxia.

Conclusions:

• Glutathione (GSH) supplementation effectively attenuated hyperoxic lung injury in preterm rabbits.
• GSH administration preserved lung mechanics and reduced edema and cell damage associated with oxygen exposure.
• These findings suggest that GSH is a potential therapeutic agent for preventing or treating oxygen-induced lung injury in vulnerable neonates.